Ελλάδα - Ελληνικά - Εθνικός Οργανισμός Φαρμάκων

baxter hellas ΕΠΕ - hydroxyethylstarch - ΕΝΕΣΙΜΟ ΔΙΑΛΥΜΑ ΓΙΑ ΕΝΔΟΦΛΕΒΙΑ ΕΓΧΥΣΗ - 6%+0.9% - ΦΑΡΜΑΚΕΥΤΙΚΟ ΠΡΟΪΟΝ

Ελλάδα - Ελληνικά - Εθνικός Οργανισμός Φαρμάκων

baxter hellas ΕΠΕ - hydroxyethylstarch - ΕΝΕΣΙΜΟ ΔΙΑΛΥΜΑ ΓΙΑ ΕΝΔΟΦΛΕΒΙΑ ΕΓΧΥΣΗ - 10%+0.9% - ΦΑΡΜΑΚΕΥΤΙΚΟ ΠΡΟΪΟΝ

Ευρωπαϊκή Ένωση - Ελληνικά - EMA (European Medicines Agency)

biontech manufacturing gmbh - single-stranded, 5’-capped messenger rna produced using a cell-free in vitro transcription from the corresponding dna templates, encoding the viral spike (s) protein of sars-cov-2 - covid-19 virus infection - Εμβόλια - comirnaty 30 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older.  comirnaty 30 micrograms/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older.  comirnaty 10 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years.  comirnaty 3 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in infants and children aged 6 months to 4 years.  comirnaty original/omicron ba. 1 (15/15 micrograms)/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older who have previously received at least a primary vaccination course against covid-19. comirnaty original/omicron ba. 4-5 (15/15 micrograms)/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older. comirnaty original/omicron ba. 4-5 (5/5 micrograms)/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years. comirnaty original/omicron ba. 4-5 (5/5 micrograms)/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years.  comirnaty original/omicron ba. 4-5 (1. 5/1. 5 micrograms)/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in infants and children aged 6 months to 4 years.  comirnaty omicron xbb. 5 30 micrograms/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older. comirnaty omicron xbb. 5 10 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years. comirnaty omicron xbb. 5 10 micrograms/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years. comirnaty omicron xbb. 5 3 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in infants and children aged 6 months to 4 years. Η χρήση αυτού του εμβολίου θα πρέπει να γίνεται σύμφωνα με τις επίσημες συστάσεις.

Κύπρος - Ελληνικά - Φαρμακευτικών Υπηρεσιών του Υπουργείου Υγείας

cel chadjianastasi pharmaceutical ltd (0000010199) 25th. march str. no. 9, famagusta, 5350 - magnesium hydroxide - ΑΝΑΒΡΑΖΟΥΣΑ ΚΟΝΙΣ - 45% - magnesium hydroxide (0001309428) 45g - magnesium hydroxide

Ελλάδα - Ελληνικά - Εθνικός Οργανισμός Φαρμάκων

glaxosmithkline ΚΑΤΑΝΑΛΩΤΙΚΑ ΠΡΟΪΟΝΤΑ ΥΓΕΙΑΣ ΕΛΛΑΣ ΑΝΩΝΥΜΗ ΕΤΑΙΡΕΙΑ Δ.Τ. gsk ch ΕΛΛΑΣ ΑΕ - ΑΚΕΤΥΛΟΣΑΛΥΚΙΛΙΚΟ ΟΞΥ - ΔΙΣΚΙΟ - 500mg/tab - 0000050782 - acetylsalicylic acid - 500.000000 mg - acetylsalicylic acid

Ελλάδα - Ελληνικά - Εθνικός Οργανισμός Φαρμάκων

bristol myers squibb aebe - acetylsalicylic acid - ΚΑΨΑΚΙΟ, ΣΚΛΗΡΟ - 500mg/cap - ΦΑΡΜΑΚΕΥΤΙΚΟ ΠΡΟΪΟΝ

Ελλάδα - Ελληνικά - Εθνικός Οργανισμός Φαρμάκων

glaxosmithkline ΚΑΤΑΝΑΛΩΤΙΚΑ ΠΡΟΪΟΝΤΑ ΥΓΕΙΑΣ ΕΛΛΑΣ ΑΝΩΝΥΜΗ ΕΤΑΙΡΕΙΑ Δ.Τ. gsk ch ΕΛΛΑΣ ΑΕ - ΑΚΕΤΥΛΟΣΑΛΥΚΙΛΙΚΟ ΟΞΥ - ΔΙΣΚΙΟ - 324mg/tab - 0000050782 - acetylsalicylic acid - 324.000000 mg - acetylsalicylic acid

Ελλάδα - Ελληνικά - Εθνικός Οργανισμός Φαρμάκων

virbac s.a., carros, france (0000006112) 1 avenue 2065,,m-lid 06516 carros,fr - aluminium hydroxide gel; ΕΝΑΙΩΡΗΜΑ ΑΔΡΑΝΟΠΟΙΗΜΕΝΟΥ ΣΤΕΛΕΧΟΥΣ ΙΟΥ ΛΥΣΣΑΣ vp; phosphate buffer solution - ΕΝΕΣΙΜΟ ΕΝΑΙΩΡΗΜΑ - - - aluminium hydroxide gel 0,10 inj.susp -; ΕΝΑΙΩΡΗΜΑ ΑΔΡΑΝΟΠΟΙΗΜΕΝΟΥ ΣΤΕΛΕΧΟΥΣ ΙΟΥ ΛΥΣΣΑΣ vp 1,00 inj.susp -; phosphate buffer solution 0,20 inj.susp - - rabies virus - Σκύλοι; Γάτες - Χρόνοι αναμονής: Γάτες; Σκύλοι

Ελλάδα - Ελληνικά - Εθνικός Οργανισμός Φαρμάκων

sanofi pasteur europe, france - ΚΑΘΑΡΙΣΜΕΝΟ ΤΟΞΟΕΙΔΙΟ diphteria, ΚΑΘΑΡΙΣΜΕΝΟ ΤΟΞΟΕΙΔΙΟ tetanus - ΕΝΕΣΙΜΟ ΕΝΑΙΩΡΗΜΑ - (2+20)iu (adults) - ineof00246 - purified diphteria toxoid - 4.000000 iu; ineof00247 - purified tetanus toxoid - 40.000000 iu - tetanus toxoid, combinations with diphtheria toxoid

Κύπρος - Ελληνικά - Φαρμακευτικών Υπηρεσιών του Υπουργείου Υγείας

remedica ltd (0000003171) aharnon str., lemesos, 3056 - magnesium trisilicate; hydrated aluminium oxide - tablet,chewable - 500mg/250mg - magnesium trisilicate (0014987043) 500mg; hydrated aluminium oxide (8000004714) 250mg - combinations